ARTIVION, INC. Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
ARTIVION, INC. (AORT) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $170.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2026-02-18
- ARTIVION, INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for the quarter ending 2019-12-31 was -$20.00K.
- ARTIVION, INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for the quarter ending 2015-12-31 was $110.00K.
- ARTIVION, INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for the quarter ending 2015-09-30 was $794.00K.
- ARTIVION, INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2025 was $170.00K, a 2.86% decline from fiscal 2024.
- ARTIVION, INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2024 was $175.00K, a 10.76% increase from fiscal 2023.
- ARTIVION, INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2023 was $158.00K, a 21.00% decline from fiscal 2022.
- ARTIVION, INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2022 was $200.00K, a 17.01% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 3 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 6 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 9 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month |
|---|---|---|---|---|
| 2025-12-31 | $170.00K 10-K · filed 2026-02-18 | |||
| 2024-12-31 | $175.00K 10-K · filed 2026-02-18 | |||
| 2023-12-31 | $158.00K 10-K · filed 2026-02-18 | |||
| 2022-12-31 | $200.00K 10-K · filed 2025-02-28 | |||
| 2021-12-31 | $241.00K 10-K · filed 2024-02-23 | |||
| 2020-12-31 | $1.70M 10-K · filed 2023-02-23 | |||
| 2019-12-31 | -$20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $880.00K 10-K · filed 2022-02-22 | ||
| 2019-09-30 | $900.00K 10-Q · filed 2019-10-31 | |||
| 2018-12-31 | $467.00K 10-K · filed 2021-02-23 | |||
| 2017-12-31 | $254.00K 10-K · filed 2020-02-19 | |||
| 2016-12-31 | $227.00K 10-K · filed 2019-02-26 | |||
| 2015-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $904.00K derived: sum of 2 quarters · filed 2018-03-09 | $904.00K 10-K · filed 2018-03-09 | |
| 2015-09-30 | $794.00K 10-Q · filed 2015-10-27 | $794.00K 10-Q · filed 2015-10-27 | ||
| 2014-12-31 | $490.00K 10-K · filed 2017-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |